FdaApplication
NDA 211746
Identifiers
- fda_app_no: NDA211746
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK SPECIALTY SA |
| application_type | NDA |
| approval_date | 2022-01-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RYALTRIS | MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE | 0.025MG/SPRAY;0.665MG/SPRAY | SPRAY, METERED;NASAL |
1 product